[HTML][HTML] STING signaling and host defense against microbial infection

J Ahn, GN Barber - Experimental & molecular medicine, 2019 - nature.com
The first line of host defense against infectious agents involves activation of innate immune
signaling pathways that recognize specific pathogen-associated molecular patterns …

[HTML][HTML] Viral oncology: molecular biology and pathogenesis

UN Mui, CT Haley, SK Tyring - Journal of clinical medicine, 2017 - mdpi.com
Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …

Integrated molecular analysis of adult T cell leukemia/lymphoma

K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi… - Nature …, 2015 - nature.com
Adult T cell leukemia/lymphoma (ATL) is a peripheral T cell neoplasm of largely unknown
genetic basis, associated with human T cell leukemia virus type-1 (HTLV-1) infection. Here …

Bacterial biofilm infection detected in breast implant–associated anaplastic large-cell lymphoma

H Hu, K Johani, A Almatroudi, K Vickery… - Plastic and …, 2016 - journals.lww.com
Background: A recent association between breast implants and the development of
anaplastic large-cell lymphoma (ALCL) has been observed. The purpose of this study was to …

Identification of multiple potential viral diseases in a large urban center using wastewater surveillance

C McCall, H Wu, B Miyani, I Xagoraraki - Water research, 2020 - Elsevier
Viruses are linked to a multitude of human illnesses and can disseminate widely in
urbanized environments causing global adverse impacts on communities and healthcare …

Treatment and survival among 1594 patients with ATL

H Katsuya, K Ishitsuka, A Utsunomiya… - Blood, The Journal …, 2015 - ashpublications.org
Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature T lymphocytes caused by
human T-lymphotropic virus type I. Intensive combination chemotherapy and allogeneic …

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

K Izutsu, S Makita, K Nosaka, M Yoshimitsu… - Blood, 2023 - ashpublications.org
Adult T-cell leukemia/lymphoma (ATL) is an aggressive non-Hodgkin lymphoma with poor
prognosis and few treatment options for patients with relapsed, recurrent, or refractory …

Whole-genome landscape of adult T-cell leukemia/lymphoma

Y Kogure, T Kameda, J Koya… - Blood, The Journal …, 2022 - ashpublications.org
Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically
resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here, we …

[HTML][HTML] Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international …

MA Kharfan-Dabaja, A Kumar, E Ayala… - Biology of Blood and …, 2017 - Elsevier
Recognizing the significant biological and clinical heterogeneity of mature T cell and natural
killer (NK)/T cell lymphomas, the American Society for Blood and Marrow Transplantation …

Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1–infected T cells

T Watanabe - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell
leukemia virus type 1 (HTLV-1) that develops through a multistep carcinogenesis process …